Related Experiment Video
Updated: Jul 28, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Thrombolytic therapy for acute myocardial infarction
F L Meister1, K A Stringer, S A Spinler
1Hoag Memorial Hospital, Newport Beach, California, USA.
Pharmacotherapy
|August 6, 1998
Summary
Pharmacists play a crucial role in managing thrombolytic agents for acute myocardial infarction. Their expertise ensures optimal drug therapy, patient care, and cost-effectiveness in treatment guidelines.
Area of Science:
- Pharmacoeconomics and Clinical Pharmacy
Background:
- Acute myocardial infarction treatment involves complex factors influencing drug formulary decisions.
- Evolving clinical trial data continuously update treatment options, predicted outcomes, and economic impacts.
Purpose of the Study:
- To highlight the multifaceted role of pharmacists in the management of thrombolytic agents for acute myocardial infarction.
- To emphasize pharmacist contributions to patient care, guideline development, and economic evaluations.
Main Methods:
- Review of factors influencing formulary status of thrombolytic agents.
- Analysis of the evolving landscape of acute myocardial infarction treatment from clinical trials.
- Description of pharmacist responsibilities in drug evaluation, procurement, monitoring, and education.
Main Results:
- Clinical trials provide ongoing data on treatment efficacy, outcomes, and economic consequences.
- Pharmacists are integral to patient care, managing drug therapy and ensuring appropriate agent selection.
- Pharmacist involvement in guideline development and outcome evaluation is critical.
Conclusions:
- Pharmacists significantly contribute to the healthcare team by optimizing drug therapy for acute myocardial infarction.
- Their role extends to economic assessment and education, improving overall patient care and resource management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.